• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.08% Nasdaq Down 0.22%

    Nivalis Therapeutics, Inc. (NVLS)

    -NasdaqGM
    14.29 Down 0.14(0.97%) 3:28PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:14.43
    Open:14.59
    Bid:14.22 x 200
    Ask:14.28 x 100
    1y Target Est:46.97
    Beta:1.46
    Next Earnings Date:N/A
    Day's Range:14.18 - 14.59
    52wk Range:13.70 - 20.43
    Volume:22,967
    Avg Vol (3m):205,407
    Market Cap:220.81M
    P/E (ttm):N/A
    EPS (ttm):-7.28
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-12) :N/A
    Quarterly EPS Est (Jun-12) :N/A
    Mean Recommendation*:2.9
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Nivalis Therapeutics, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of product candidates for patients with cystic fibrosis (CF). View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback